ERYP - Erytech Pharma - ADR
Close
0.79
-0.030 -3.797%
Share volume: 0
Last Updated: Thu 29 Jun 2023 10:00:00 PM CEST
Biological Product (except Diagnostic) Manufacturing :
-3.41%
PREVIOUS CLOSE
CHG
CHG%
$0.82
-0.03
-3.66%
Fundamental analysis
76%
Profitability
93%
Dept financing
25%
Liquidity
0%
Performance
90%
Performance
5 Days
-10.86%
1 Month
-10.02%
3 Months
-15.50%
6 Months
136.29%
1 Year
-31.58%
2 Year
-83.58%
Key data
Stock price
$0.79
DAY RANGE
N/A - N/A
52 WEEK RANGE
$0.30 - $1.47
52 WEEK CHANGE
-$0.30
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
Company detail
CEO: Gil Beyen
Region: US
Website: http://erytech.com/
Employees: 181
IPO year: -
Issue type: American Depository Receipt (ADR’s)
Market: XNAS
Industry: Biological Product (except Diagnostic) Manufacturing
Sector: Manufacturing
Region: US
Website: http://erytech.com/
Employees: 181
IPO year: -
Issue type: American Depository Receipt (ADR’s)
Market: XNAS
Industry: Biological Product (except Diagnostic) Manufacturing
Sector: Manufacturing
Recent news